article thumbnail

Re-Imagining Med Chem Strategies: the Tyranny of the n+1 Compound

DrugBaron

A lot of resources are therefore poured into synthetic chemistry, and if the compound family is at all synthetically challenging it can require dozens, even hundreds, of chemists to churn out every imaginable variant.

article thumbnail

Synthetic Origins

Codon

It really fits perfectly, and it is analogous to chemistry, where you've got synthetic chemistry and analytical chemistry. Slides from a lab talk presented in Heidelberg, Germany in 1998. Elowitz: I always liked the term. And in terms of the field, yeah, I do.

RNA 55
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug Discovery and Medicinal Chemistry in the Era of Automation - Webinar Recap

The Strateos Blog: Drug Discovery

Director of Chemistry of Strateos gave an interactive talk focused on how automated robotics and integrated software are powering self-driving labs that are revolutionizing synthetic chemistry to support medicinal chemistry workflows. Director of R&D Strategy and Vince Yeh, Ph.D., " - Vince Yeh, Ph.D.,

article thumbnail

Highlights from SLAS 2022 Conference - Event Recap

The Strateos Blog: Drug Discovery

The recent SLAS 2022 conference showcased some great presentations and panel discussions on the transformative potential of laboratory automation and AI-driven machine learning. The focus of this year’s SLAS 2022 was to accelerate life sciences research through the adoption and integration of transformative lab automation technologies.